Allergy Shot Therapy: The Only Disease-Modifying Treatment for Allergic Disease
Allergy shot therapy refers unambiguously to subcutaneous immunotherapy (SCIT) — the 3-to-5-year therapeutic course of escalating allergen extract injections per Cox 2011 PP3. Cox, Murphey, and Hankin (Immunol Allergy Clin North Am 2020) classify SCIT as the only disease-modifying allergy therapy with long-term remission documented in randomized trials. Durham 1999 NEJM confirmed a 3-year course produces 4 additional years of durable benefit post-discontinuation.
7 peer-reviewed sources
Allergy shot therapy is subcutaneous immunotherapy (SCIT) — the 3-to-5-year multi-year injection course that is the only disease-modifying allergy therapy with documented post-treatment remission. It differs from symptom-suppressing treatments because benefits persist years after stopping.
The essentials
Allergy shot therapy maps directly to subcutaneous immunotherapy (SCIT) in clinical terminology. The 'therapy' suffix is doing important semantic work: it distinguishes SCIT as a multi-year therapeutic course from symptomatic interventions like antihistamines, nasal corticosteroids, or one-time depot steroid injections. Cox L, Murphey A, and Hankin C (Immunol Allergy Clin North Am 2020;40[1]:69-85, PMID 31761122) explicitly classify SCIT as the only disease-modifying allergy therapy with long-term remission documented in randomized controlled trials — a designation that no other allergy intervention meets.
The 'therapy' framing implies, correctly, that the searcher understands they are looking at a multi-year commitment. The treatment-course architecture of SCIT consists of two phases. The build-up phase runs approximately 4-6 months, with 1-2 injections per week escalating from 1,000- to 10,000-fold below the maintenance dose across approximately 26-28 visits. The maintenance phase then continues every 2-4 weeks for a total course of 3-5 years, per Cox 2011 PP3 (JACI 2011;127[1 Suppl]:S1-S55). A mandatory 30-minute post-injection observation period applies at every single visit.
The biologics (Xolair/omalizumab, Dupixent/dupilumab, Tezspire/tezepelumab) also use the word 'therapy' in their marketing — but none of them meets the clinical bar for disease-modifying therapy in the immunotherapy sense. They treat IgE-mediated or Th2-mediated disease without inducing allergen-specific tolerance. Symptoms return on discontinuation. SCIT is uniquely different because the immune changes it induces — Treg expansion, blocking IgG4, mast-cell downregulation — persist years after the injection course ends.
Before beginning allergy shot therapy, identifying the correct allergen targets is essential. Curex pairs at-home IgE testing with allergist review to identify the specific allergens that should be included in any immunotherapy regimen — the same diagnostic step that precedes SCIT extract preparation under Cox 2011.
How allergy shots retrain your immune system
The 'therapy' designation for SCIT reflects a molecular-level disease modification rather than symptom suppression. SCIT shifts allergen-specific immunity from a Th2-driven inflammatory phenotype to regulatory T-cell-mediated tolerance through FOXP3+ Treg expansion, IL-10 and TGF-beta production, B-cell class-switching from IgE to IgG4, and progressive reduction in mast-cell and eosinophil populations in target tissues. These changes accumulate over months to years and persist for years after the injection course ends via long-lived allergen-specific IgG4-producing plasma cells in bone marrow niches — the molecular basis of durable post-treatment remission.
Allergen identification (diagnostic prerequisite)
Skin prick testing or specific-IgE blood testing confirms IgE sensitization to specific allergens. Only sensitized allergens are included in the therapeutic extract mixture — without this step the therapy cannot be correctly targeted.
Build-up: escalating doses over 4-6 months
Weekly injections starting at sub-threshold doses and incrementing toward the maintenance level. A 30-minute post-injection observation period is mandatory per Cox 2011 PP3. Early immune changes — basophil desensitization, initial IgG4 rise — begin during this phase.
Maintenance: sustained therapy for 3-5 years
Every 2-4 week injections consolidate Treg populations and IgG4 production. Symptom improvement continues to accumulate. Completing the full course is required for post-discontinuation durability.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Framing SCIT as 'therapy' versus 'treatment' usefully distinguishes it from the other injectable allergy interventions, which treat disease or suppress symptoms without inducing the durable immune tolerance that defines a therapy in the disease-modifying sense.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergy shot therapy) | |||||
Xolair (omalizumab) | |||||
SLIT drops (sublingual therapy) | |||||
Intranasal corticosteroids |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients ready for a multi-year disease-modifying course but not for years of weekly clinic trips, Curex delivers the SCIT shot itself at home for $129/month — the same Treg-induction, blocking-IgG4 therapy, now self-administered weekly. A board-certified allergist designs the plan, the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and your first dose and every dose change are supervised live over Zoom.
See if at-home shots are right for youFrequently asked questions
What makes allergy shot therapy different from other allergy treatments?
Allergy shot therapy (SCIT) is the only allergy treatment classified as disease-modifying in a peer-reviewed analysis: Cox, Murphey, and Hankin (Immunol Allergy Clin North Am 2020;40[1]:69-85) documented that SCIT is the only treatment with long-term remission demonstrated in randomized controlled trials. All other treatments — antihistamines, nasal corticosteroids, biologics like Xolair and Dupixent — suppress symptoms or control disease while the treatment continues, but provide no lasting benefit after discontinuation. SCIT retrains the immune system through allergen-specific regulatory T cells and blocking IgG4 antibodies, producing changes that persist for years after the full 3-5 year course is completed.
How long does allergy shot therapy take to work?
Most patients on SCIT notice meaningful symptom improvement within 3-6 months of reaching the maintenance dose, though some require 12 full months at maintenance before clear benefit emerges. The full disease-modifying effect accumulates over the complete 3-5 year therapeutic course. The AAAAI/ACAAI Practice Parameter recommends assessing effectiveness after 12 months at maintenance before considering discontinuation for non-response — attempting to judge the therapy at 2-3 months of build-up is premature. Full disease-modifying changes at the immunological level (sustained Treg populations, consolidated IgG4 blocking antibodies) develop progressively across the entire multi-year course.
Is allergy shot therapy covered by insurance?
Most major US commercial insurance plans cover SCIT as medically necessary for allergic rhinitis, allergic asthma, and Hymenoptera venom allergy. Coverage typically requires prior authorization demonstrating documented IgE sensitization and inadequate response to pharmacotherapy. Medicare Part B covers allergy immunotherapy under the physician services benefit with 20% coinsurance after the annual deductible. The relevant CPT codes are 95115 (single injection) and 95117 (two or more injections per visit) for administration, and 95165 (extract preparation, per dose). Medicaid coverage and access to board-certified allergists varies substantially by state — Wu I et al (AAAAI 2019) found 82% of US counties have zero board-certified allergists.
What are the risks of allergy shot therapy?
Local injection-site reactions (redness, swelling, itching) are common — occurring in approximately 20-70% of patients — and represent expected immune activation, not dangerous reactions. Systemic reactions (hives, sneezing, mild wheezing) occur in approximately 0.1% of injection visits per Epstein TG et al (Ann Allergy Asthma Immunol 2013/2014). Fatal reactions are extremely rare: one per 23.3 million injection visits in the 2008-2012 surveillance period. Patients with uncontrolled asthma (FEV1 below 70% predicted) should not receive injections on that day. The mandatory 30-minute post-injection observation period is the most critical safety measure.
How many injections does allergy shot therapy involve per year?
In Year 1, SCIT involves approximately 39 clinic visits — roughly 26-28 weekly build-up injections plus approximately 13 early-maintenance visits spaced every 2-4 weeks, per Cox 2011 PP3. In Years 2 through 5, the maintenance-phase injection frequency drops to every 2-4 weeks, resulting in approximately 14-26 visits per year depending on the chosen interval. Over a complete 3-year course, most patients receive approximately 57-60 total injections. Each visit requires a mandatory 30-minute observation period, making each appointment approximately 45 minutes total — roughly 110 hours of cumulative clinic time for a 3-year course.
Can allergy shot therapy prevent asthma from developing?
Allergy shot therapy has the strongest evidence for asthma prevention of any allergy intervention. The Preventive Allergy Treatment (PAT) study, with 10-year follow-up published by Jacobsen L et al (Allergy 2007;62:943-948), found that a 3-year pollen SCIT course in children with allergic rhinitis reduced the subsequent development of asthma by approximately half compared to controls, with this protective effect persisting at 10-year follow-up. Möller C et al (JACI 2002) confirmed the early asthma-prevention signal. No pharmacotherapy — antihistamines, nasal corticosteroids, or biologics — has demonstrated comparable asthma-prevention evidence in pediatric populations.
What happens after allergy shot therapy is completed?
After completing a 3-5 year SCIT course, no further injections are typically required unless symptoms return. Disease-modifying effects persist for years after the last injection — Durham SR et al (NEJM 1999) documented that patients 4 years after stopping a 3-year grass-pollen course had symptom and medication scores comparable to patients still on treatment. The molecular basis for this durability is long-lived allergen-specific IgG4-producing plasma cells in bone marrow niches that continue producing blocking antibodies without further antigen stimulation. A minority of patients eventually re-sensitize and benefit from a repeat course, but most do not require ongoing therapy.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Vaccine Name – What Is the SCIT / SLIT Brand Called?
SCIT (allergy shots) has no brand name — extracts are custom-mixed. SLIT tablets have four FDA-approved brands: Grastek, Oralair, Ragwitek, Odactra.
Read moreTired After Allergy Shots — What the Data Shows | Curex
Fatigue after allergy shots is real and patient-reported — but no peer-reviewed surveillance quantifies its prevalence. Here is what is actually known and what is not.
Read moreNames of Allergy Shots: Complete Guide | Curex
Names of allergy shots: SCIT, AIT, hyposensitization, allergy vaccine (WHO 1998). Brands belong to SLIT tablets, biologics, and steroids — not SCIT itself.
Read moreAllergy Medicine Shot: SCIT vs Xolair vs Steroids | Curex
Allergy medicine shots include SCIT (allergen extract, not a drug), Xolair, Dupixent, and depot steroids. Only SCIT modifies disease. AAAAI discourages routine steroid shots.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.